Abstract
The use of botulinum toxin type A purified neurotoxin complex and peripheral neurostimulation are now established approaches in the management of the highly disabling primary headache syndromes migraine and cluster headache.
Original language | English |
---|---|
Pages (from-to) | 69-71 |
Number of pages | 4 |
Journal | Medicine Today |
Volume | 17 |
Issue number | 6 |
Publication status | Published - 1 Jun 2016 |